Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers

Oncology Reports

Volumn 9, Issue 4, 2002, Pages 793-799

  Tsutsui, Shinichi ^a   Ohno, Shinji ^b   Murakami, Shigeru ^b   Kataoka, Akemi ^b   Kinoshita, Junko ^b   Hachitanda, Yoichi ^b  

^a NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Aneuploidy; Breast cancer; DNA ploidy; Heterogeneity

Indexed keywords

DNA; PARAFFIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PLOIDY; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PARAFFIN EMBEDDING; PLOIDIES; PROGNOSIS;

EID: 0036635229     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.4.793     Document Type: Article

References (26)

1. Nicholson RI, McClelland RA, Finlay P, et al: Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A: 1018-1023, 1993. (Pubitemid 23126705)
2. Kandioler-Eckersberger D, Ludwig C, Rudas M, et al: TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res 6: 50-56, 2000. (Pubitemid 30064975)
3. Tsutsui S, Kuwano H, Mori M, Matsuura H and Sugimachi K: Comparison of cell nuclear DNA contents between intraepithelial and invasive components of oesophageal squamous cell carcinoma. Eur J Cancer 27: 620-624, 1991.
4. Iglehart JD, Kerns BJ, Huper G and Marks JR: Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer. Breast Cancer Res Treat 34: 253-263, 1995.
5. Davidoff AM, Kerns BM, Iglehart JD and Marks JR: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51: 2605-2610, 1991.
6. Tsutsui S, Ohno S, Murakami S, Hachitanda Y and Oda S: Prognostic value of DNA ploidy in 653 Japanese women with node negative breast cancer. Int J Clin Oncol 6: 177-182, 2001. (Pubitemid 32899618)
7. Kallioniemi OP, Blanco G, Alavaikko M, et al: Tumor DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 56: 637-642, 1987. (Pubitemid 17165663)
8. Silvestrini R, Daidone MG, Del Bino G, et al: Prognostic significance of prolirefative activity and ploidy in node-negative breast cancers. Ann Oncol 4: 213-219, 1993. (Pubitemid 23121661)
9. Baildam AD, Zaloudik J, Howell A, et al: DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer 55: 553-559, 1987. (Pubitemid 17098867)
10. O'Reilly SM, Camplejohn RS, Rubens RD and Richards MA: DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. Eur J Cancer 28: 681-683, 1992.
11. Watanabe M, Kuwano H, Tanaka S, Toh Y, Sadanaga N and Sugimachi K: Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus. Cancer 85: 2322-2328, 1999. (Pubitemid 29244838)
12. Schackney SE, Berg G, Simon SR, et al: Origins and clinical implications of aneuploidy in early bladder cancer. Cytometry 22: 307-316, 1995. (Pubitemid 26047305)
13. Kallioniemi OP: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9: 164-169, 1988.
14. Fuhr JE, Frye A, Kattine AA and van Meter S: Flow cytometric determination of breast tumor heterogeniety. Cancer 67: 1401-1405, 1991.
15. Toikkanen S, Joensuu H and Klemi P: The prognostic significance of nuclear DNA content in invasive breast caner - a study with long-term follow-up. Br J Cancer 60: 693-700, 1989. (Pubitemid 19275733)
16. Beerman H, Smit VTHBM, Kluin PM, Bonsing BA, Hermans J and Cornelisse CJ: Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry 12: 147-154, 1991.
17. Van Dam PA, Bockestaele DRV, Keersmaeckers GH and Uyttenbroeck FL: Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma. Cytometry 11: 300-307, 1990. (Pubitemid 20097238)
18. Frankfurt OS, Slocum HK, Rustum YM, et al: Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry 5: 71-80, 1984.
19. Feicher GE, Kaufmann M, Muller A, Haag D, Eckhardt R and Goerttker K: DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases. Breast Cancer Res Treat 13: 17-22, 1989.
20. Kang H, Youn Y, Oh S, Choe KJ and Noh D: Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Breast Cancer Res Treat 63: 81-87, 2000.
21. Vindelov LL, Christensen IJ and Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983. (Pubitemid 13087609)
22. Tsutsui S, Kuwano H, Mori M, Matsuura H and Sugimachi K: A flow cytometric analysis of DNA content in primary and metastaic lesions of esophageal squamous cell carcinoma. Cancer 70: 2586-2591, 1992.
23. Auer GU, Fallenius AG, Erhardt KY and Sundelin BSB: Progression of mammary adenocarcinomas as reflected by nuclear DNA content. Cytometry 5: 420-425, 1984. (Pubitemid 14064796)
24. Korenaga D, Haraguchi M, Okamura T, et al: Consistency of DNA ploidy between primary and recurrent gastric carcinomas. Cancer Res 46: 1544-1546, 1986. (Pubitemid 16048311)
25. Backdahl M, Cohn K, Auer G, et al: Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma. Cancer Res 45: 2890-2894, 1985. (Pubitemid 15232765)
26. American Society of Clinical Oncology: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 14: 2843-2877, 1996.